Biogen (NASDAQ:BIIB) stock traded flat as the company reports better than expected Q4 2024 financials, but its 2025 outlook ...

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

Biogen forecast 2025 profit below last year's levels and Wall Street expectations on Wednesday, hurt by a strong dollar and ...

The researchers found that mothers who were exposed to sunlight during their pregnancy, especially during the second ...

is a common test doctors use to check for signs of MS in your spinal fluid. But a lumbar puncture on its own isn’t enough to confirm an MS diagnosis. Diagnosing multiple sclerosis (MS ...

FDA adds boxed warning to a multiple sclerosis drug, citing rare but severe ... system’s abnormal attack on nerves in the brain and spinal cord, which helps decrease the number of MS relapses.

Turner Construction has announced the topping out of McGivney Tower, which marked the conclusion of vertical construction for the Adams Neurosciences Center at Yale New Haven Hospital, Saint ...

Multiple sclerosis (MS) is a chronic ... the immune system attacks the myelin that protects the nerve fibers in the spinal cord and brain. If you or someone you love is experiencing symptoms ...

As a global biopharmaceutical business, the company is most well known for their products in multiple sclerosis, spinal muscular atrophy, and most recently Alzheimer’s disease. The new CEO ...

As a global biopharmaceutical business, the company is most well known for their products in multiple sclerosis, spinal muscular atrophy, and most recently Alzheimer’s disease. The new CEO ...

Multiple sclerosis (MS) is a disease that affects the brain and spinal cord. It happens when the body’s immune system ...